Status:
COMPLETED
Zinc Status and Growth in Cystic Fibrosis
Lead Sponsor:
Indiana University
Conditions:
Cystic
Fibrosis
Eligibility:
All Genders
3-3 years
Brief Summary
The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.
Detailed Description
The objective of this study is to improve the understanding of the relationship of zinc (Zn) status and growth in infant and young people with cystic fibrosis (PWCF). The investigators hypothesize tha...
Eligibility Criteria
Inclusion
- Pediatric patients ages 3 months to 3 years with CF identified via new born screening
Exclusion
- History of meconium ileus
- History of prematurity (born prior to completing 36 weeks 6 days gestation)
Key Trial Info
Start Date :
August 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04302428
Start Date
August 29 2019
End Date
March 30 2021
Last Update
March 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, United States, 46202